Bavarian Nordic A/S : to Present at Biotech Showcase 2013 in San Francisco

KVISTGAARD, Denmark, January 3, 2013 - Bavarian Nordic (NASDAQ OMX: BAVA) announced today that Anders Hedegaard, President & CEO will present at the Biotech Showcase(TM) 2013 Conference in San Francisco, CA on Monday, January 7, 2013 at 11:30 am PST.

The presentation slides will subsequently be available on the company's website: www.bavarian-nordic.com/investor:
http://www.bavarian-nordic.com/investor

Biotech Showcase is an investor and partnering conference devoted to providing private and public biotechnology and life sciences companies an opportunity to present to, and meet with, investors and pharmaceutical executives during the course of one of the industry's largest annual healthcare investor conferences. The conference is taking place at Parc 55 Wyndham San Francisco - Union Square Hotel.

Contact
Rolf Sass Sørensen, Vice President Investor Relations & Communications
E-mail: [e-mail]:
mailto:[e-mail]
Phone: [phone]

About Bavarian Nordic
Bavarian Nordic is a vaccine-focused biotechnology company developing and producing novel vaccines for the treatment and prevention of life-threatening diseases with a large unmet medical need. The company's pipeline targets cancer and infectious diseases, and includes ten development programs. In oncology, the company's lead program is PROSTVAC®, a therapeutic vaccine candidate for advanced prostate cancer that is the subject of an ongoing pivotal Phase 3 trial and is being developed under a collaboration agreement with the National Cancer Institute. In clinical Phase 1 and Phase 2 trials, PROSTVAC® has been tested in nearly 600 patients. In infectious diseases, the company's lead program is IMVAMUNE®, a non-replicating smallpox vaccine candidate that is being developed and supplied for emergency use to the U.S. Strategic National Stockpile under a contract with the U.S. Government. For more information, visit www.bavarian-nordic.com:
http://www.bavarian-nordic.com

---

This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients.

The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and other applicable laws; and
(ii) they are solely responsible for the content, accuracy and originality of the
information contained therein.

Source: Bavarian Nordic A/S via Thomson Reuters ONE

HUG#1667986

Share

© GlobeNewswire - 2013